Important status note: Retatrutide is investigational. It is not FDA-approved, it has never been FDA-approved, and there is no authorized consumer supply. PlexusDx does not sell, distribute, or prescribe retatrutide or any other investigational peptide in this category.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Weight loss peptide research has expanded significantly in recent years, moving beyond single-mechanism GLP-1 compounds toward multi-target therapies designed to address metabolic dysfunction from multiple angles. PlexusDx specializes in precision peptide therapy, offering patients access to advanced compounded options paired with genetic insight to describe the pathway-level variants involved.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Understanding Next-Generation Peptide Mechanisms
First-generation GLP-1 agonists like semaglutide work by activating glucagon-like peptide-1 receptors in the brain and pancreas, reducing appetite and improving blood sugar control. Newer peptides introduce additional receptor activation—such as gastric inhibitory peptide (GIP) or glucagon receptors—to create synergistic metabolic effects. These multi-target approaches aim to address weight regain and metabolic adaptation that can occur with single-mechanism therapies over time.
Clinical research demonstrates that dual and triple-agonist peptides may produce greater weight loss and metabolic improvements compared to GLP-1 monotherapy in some patient populations. However, individual response varies considerably based on genetic factors, lifestyle, and baseline metabolic health. This variability is precisely why PlexusDx offers the Precision Peptide Genetic Test—to map your individual peptide-pathway genetics and guide therapy selection.
Peptide Options Available Through PlexusDx
PlexusDx provides access to multiple peptide formulations sourced from licensed 503A compounding pharmacies across all 50 states. Semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) and remains the most studied GLP-1 option, with over a decade of real-world safety data. For patients seeking dual-action therapy, PlexusDx offers GLP-Squared (a compounded combination of semaglutide and tirzepatide) at $289/mo month-to-month, or from $249/mo on the 6-month plan, providing simultaneous GLP-1 and GIP receptor activation.
Tirzepatide injection, available as a standalone therapy at $289/mo month-to-month, or from $249/mo on the 6-month plan, activates both GLP-1 and GIP receptors in a single compound. Oral formulations of semaglutide and tirzepatide offer an injection-free alternative for patients who prefer oral administration, beginning at $289 and $349 per month respectively. The Microdose GLP-1 Protocol ($129/mo) provides a lower-dose entry point for those optimizing tolerability or exploring peptide therapy for the first time.
The Role of Genetic Testing in Peptide Selection
PlexusDx's Precision Peptide Genetic Test ($99 add-on after first month of treatment) examines key genetic variants across 14 metabolic pathways, including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313. These variants influence how your body responds to appetite-regulating peptides, insulin secretion, and fat storage—directly informing which peptide mechanism may produce the strongest metabolic response in your individual biology.
Mapping 49 peptides across 150+ genetic insights, the test helps identify whether you are more likely to respond to GLP-1 monotherapy, dual-agonist peptides, or require a specialized dosing approach. This genetic roadmap reduces trial-and-error therapy selection and accelerates the path to your optimal weight loss outcome. Precision Peptide Genetic Testing represents the intersection of pharmacogenomics and personalized medicine—transforming peptide therapy from a one-size-fits-most approach into truly individualized precision health.
Cost, Access, and Insurance Coverage
PlexusDx eliminates common barriers to peptide therapy: no membership fee, no insurance requirement, and no state restrictions. All therapies are HSA and FSA eligible, allowing patients to use pre-tax healthcare savings accounts. Monthly pricing remains flat regardless of dose level—your dose may need to go up, but your price won't—ensuring predictable out-of-pocket costs as you optimize your therapy.
Compounded peptides from licensed 503A pharmacies offer significant cost savings compared to brand-name GLP-1 medications, with transparency built into every plan. Whether you select semaglutide injection at $189/mo (or $149/mo on the 6-month plan) or explore dual-action peptides, the month-to-month rate is the price you see, with multi-month plans available as an optional discount for patients who choose to commit. This direct-to-patient model removes pharmacy markup, enabling affordable access to advanced peptide therapy for patients across all 50 states.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the difference between semaglutide and newer peptide options like tirzepatide?
Semaglutide activates only the GLP-1 receptor, whereas tirzepatide and dual-agonist formulations activate both GLP-1 and GIP receptors simultaneously. This dual activation may produce greater weight loss and metabolic improvement in some patients, though individual response depends on genetic factors. PlexusDx's Precision Peptide Genetic Test describes the pathway-level variants involved.
Do compounded peptides work as well as brand-name medications?
Compounded semaglutide and tirzepatide from licensed 503A pharmacies contain identical active pharmaceutical ingredients to brand-name formulations, manufactured under strict quality and sterility standards. Clinical efficacy is equivalent; the primary difference is cost and accessibility. PlexusDx sources exclusively from licensed 503A compounding pharmacies, never 503B facilities, ensuring the highest compounding standards.
How much does peptide therapy cost with PlexusDx?
PlexusDx prices remain flat per compound regardless of dose: Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan), Tirzepatide Injection at $289/mo (or $249/mo on the 6-month plan), and GLP-Squared (dual-agonist) at $289/mo (or $249/mo on the 3-month plan). The Precision Peptide Genetic Test adds $99 after your first month. All plans are HSA/FSA eligible with no insurance required, and pricing may decrease with longer commitment tiers.
What side effects should I expect from peptide therapy?
Common side effects include nausea, vomiting, and gastrointestinal changes, typically mild and transient during dose titration. The Microdose GLP-1 Protocol ($129/mo) offers a lower-dose entry point to improve tolerability. Serious side effects are rare; however, peptides are not appropriate for individuals with personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia Type 2.
How does the Precision Peptide Genetic Test help me choose the right therapy?
The test examines variants in GLP1R, GIPR, FTO, MC4R, and 10 additional metabolic pathways, mapping 49 peptides across 150+ genetic insights. This data identifies whether your biology favors single-mechanism GLP-1 therapy, dual-agonist peptides, or specialized dosing protocols. Knowing your genetic predispositions eliminates guesswork and accelerates your path to optimal weight loss outcomes.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Real prescribers. Published prices. No surprises.
Licensed providers in all 50 states. Online intake. No insurance, no membership required.
Start My Intake →~60 seconds · $0 charged until your provider approves
Share:
What Can Stop Mounjaro Working: Identifying and Overcoming Challenges
What Type of Drug Is Mounjaro? A Deep Dive into Its Function and Role in Managing Type 2 Diabetes